Over 30 million Americans suffer from ED (erectile dysfunction). According to a new study published by the journal Clinical and Developmental Immunology and the National Institute of Health, cannabis naturally activates the body’s cannabinoid receptors, which can actually reduce the risk of ED in those with hypercholesterolemia, or high levels of blood-cholesterol levels.
According to the study’s lead researcher, “Hypercholesterolemia is one of the most important risk factors for erectile dysfunction, mostly due to the impairment of oxidative stress and endothelial function in the penis.”
The team studied the effects of cannabinoid receptor activation on mice with high cholesterol. Data suggests that CB2 activation improves the oxidative stress and fibrosis deposition in hypercholesterolemic condition. The results of this study indicate the potential of cannabinoids and cannabis in the treatment of ED.